National Jewish Health

The board of directors governs financial oversight. Evan Zucker, managing partner at Ares Management, serves as board chair. Former chairs include Blair Richardson, managing partner of Bow River Capital, and Richard Baer, an executive at Liberty Media. Day-to-day operational leadership is held by President and CEO Dr. Michael Salem.

The institution is a nonprofit hospital and research center, not a family office. Its funding flows from philanthropy, federal research grants, and clinical revenue. Named major donors include the Arthur M. Blank Family Foundation and the Morgridge Family Foundation, whose contributions endowed the Morgridge Academy.

Yes. The Molly Blank Pediatric Care Fund operates as a restricted philanthropic program for children with respiratory and atopic diseases. It sits within the larger hospital structure but maintains dedicated programming and donor designation. The Morgridge Academy, an on-site K-8 charter school for chronically ill children, is a separately endowed program.

As a medical research nonprofit, National Jewish Health does not make financial co-investments alongside GPs in the private-markets sense. Partnerships are programmatic and philanthropic: the Arthur M. Blank Family Foundation and the Morgridge Family Foundation co-fund research and care initiatives. The institution occasionally participates in industry associations including the American Thoracic Society.

National Jewish Health operates within respiratory, immunologic, cardiac, and precision medicine research. It does not engage in for-profit venture investing, hospital-system mergers, or translational research in oncology or neuroscience. Its real estate holdings are limited to its own clinical and educational facilities on its Denver campus.